Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles

ABSTRACT The periodic emergence of infectious disease poses a serious threat to human life. Among the causative agents, including pathogenic bacteria and fungi, enveloped viruses have caused global pandemics. In the last 10 years, outbreaks of severe acute respiratory syndrome coronavirus 2 disease,...

Full description

Bibliographic Details
Main Authors: Wooil Choi, Yang-Hoon Kim, Jiho Min
Format: Article
Language:English
Published: American Society for Microbiology 2023-02-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02661-22
_version_ 1811164353446019072
author Wooil Choi
Yang-Hoon Kim
Jiho Min
author_facet Wooil Choi
Yang-Hoon Kim
Jiho Min
author_sort Wooil Choi
collection DOAJ
description ABSTRACT The periodic emergence of infectious disease poses a serious threat to human life. Among the causative agents, including pathogenic bacteria and fungi, enveloped viruses have caused global pandemics. In the last 10 years, outbreaks of severe acute respiratory syndrome coronavirus 2 disease, severe acute respiratory syndrome, and Middle East respiratory syndrome have all been caused by enveloped viruses. Among several paths of secondary transmission, inhalation of aerosols containing saliva with sputum droplets from infected patients is the major path. To prevent these infectious diseases, mass use of antiviral agents is essential. The yeast-derived vacuole is a small organelle in which hydrolytic enzymes are concentrated. It is an intracellular organ with an excellent ability to process old organelles and bacteria and viruses that have invaded from the outside and can be present in sufficient quantity to be called a kind of enzyme bomb. We confirmed the inhibition of virus infection and structural collapse by vacuole treatment. Among several enzymes, proteases affected Phi6 infectivity. This study tried to isolate these vacuoles from yeast and use them as an antiviral agent for virus treatment, which is a recent issue. We confirmed that viral infectivity was inactivated, and structure collapsed through vacuole treatment. This paper is meaningful in that extracellularly isolated yeast-derived vacuoles are a first attempt to utilize vacuoles for viral treatment. IMPORTANCE The study assesses the vacuoles isolated from the yeast Saccharomyces cerevisiae as green antiviral agents to decrease the concerns about massive use of chemical antiviral agents and its side effects. To prevent the spreading of infectious diseases, personal or public use of antiviral agents is encouraged. The concern about the active compounds of these chemical antiviral agents has grown. Active compounds of antiviral agents have potential side effects on human health and the environment. Our proposed approach suggests effective and green antivirus material from a nonhazardous yeast strain. Also, large-scale production using a fermentation process can allow cost-effectiveness. The results showed sufficient reduced infectivity by vacuole treatment. The exposed vacuole can play the roles of both enzyme bomb to the virus and renewable nutrient source in the ecosystem.
first_indexed 2024-04-10T15:20:16Z
format Article
id doaj.art-400a8df274ef41f59c9988a722da6247
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-04-10T15:20:16Z
publishDate 2023-02-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-400a8df274ef41f59c9988a722da62472023-02-14T14:15:50ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-02-0111110.1128/spectrum.02661-22Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived VacuolesWooil Choi0Yang-Hoon Kim1Jiho Min2Graduate School of Semiconductor and Chemical Engineering, Jeonbuk National University, Jeonbuk, South KoreaSchool of Biological Sciences, Chungbuk National University, Cheongju, South KoreaGraduate School of Semiconductor and Chemical Engineering, Jeonbuk National University, Jeonbuk, South KoreaABSTRACT The periodic emergence of infectious disease poses a serious threat to human life. Among the causative agents, including pathogenic bacteria and fungi, enveloped viruses have caused global pandemics. In the last 10 years, outbreaks of severe acute respiratory syndrome coronavirus 2 disease, severe acute respiratory syndrome, and Middle East respiratory syndrome have all been caused by enveloped viruses. Among several paths of secondary transmission, inhalation of aerosols containing saliva with sputum droplets from infected patients is the major path. To prevent these infectious diseases, mass use of antiviral agents is essential. The yeast-derived vacuole is a small organelle in which hydrolytic enzymes are concentrated. It is an intracellular organ with an excellent ability to process old organelles and bacteria and viruses that have invaded from the outside and can be present in sufficient quantity to be called a kind of enzyme bomb. We confirmed the inhibition of virus infection and structural collapse by vacuole treatment. Among several enzymes, proteases affected Phi6 infectivity. This study tried to isolate these vacuoles from yeast and use them as an antiviral agent for virus treatment, which is a recent issue. We confirmed that viral infectivity was inactivated, and structure collapsed through vacuole treatment. This paper is meaningful in that extracellularly isolated yeast-derived vacuoles are a first attempt to utilize vacuoles for viral treatment. IMPORTANCE The study assesses the vacuoles isolated from the yeast Saccharomyces cerevisiae as green antiviral agents to decrease the concerns about massive use of chemical antiviral agents and its side effects. To prevent the spreading of infectious diseases, personal or public use of antiviral agents is encouraged. The concern about the active compounds of these chemical antiviral agents has grown. Active compounds of antiviral agents have potential side effects on human health and the environment. Our proposed approach suggests effective and green antivirus material from a nonhazardous yeast strain. Also, large-scale production using a fermentation process can allow cost-effectiveness. The results showed sufficient reduced infectivity by vacuole treatment. The exposed vacuole can play the roles of both enzyme bomb to the virus and renewable nutrient source in the ecosystem.https://journals.asm.org/doi/10.1128/spectrum.02661-22yeast-derived vacuoleantiviral agentsenveloped virusenzyme bombinfection inhibition
spellingShingle Wooil Choi
Yang-Hoon Kim
Jiho Min
Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
Microbiology Spectrum
yeast-derived vacuole
antiviral agents
enveloped virus
enzyme bomb
infection inhibition
title Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
title_full Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
title_fullStr Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
title_full_unstemmed Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
title_short Inhibition of Enveloped Virus Surrogate Phi6 Infection Using Yeast-Derived Vacuoles
title_sort inhibition of enveloped virus surrogate phi6 infection using yeast derived vacuoles
topic yeast-derived vacuole
antiviral agents
enveloped virus
enzyme bomb
infection inhibition
url https://journals.asm.org/doi/10.1128/spectrum.02661-22
work_keys_str_mv AT wooilchoi inhibitionofenvelopedvirussurrogatephi6infectionusingyeastderivedvacuoles
AT yanghoonkim inhibitionofenvelopedvirussurrogatephi6infectionusingyeastderivedvacuoles
AT jihomin inhibitionofenvelopedvirussurrogatephi6infectionusingyeastderivedvacuoles